The Indoleamine 2,3-Dioxygenase Pathway Controls Complement-Dependent Enhancement of Chemo-Radiation Therapy Against Murine Glioblastoma
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-2-21
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
BMJ